Uzbekistan claims 18 kids died after consuming Syrup Made By Indian Company

 

Uzbekistan claims 18 kids died after consuming medicines manufactured by Indian company Marion Biotech.

New Delhi: At least 18 children in Uzbekistan are said to have died after taking a cough syrup made in India, according to the country.

According to a statement released by the Uzbek health ministry, the children who died had consumed Marion Biotech's Doc-1 Max cough syrup.

The pharmaceutical company's Noida unit has halted production of the cough syrup until the samples are tested as part of India's investigation.

As indicated by the Uzbekistan's wellbeing service, the research facility trial of a group of syrups found "the presence of ethylene glycol", a harmful substance.

In addition, it stated that the syrup was administered to children at home without a doctor's prescription, either by the children's parents or on the advice of pharmacists, in doses that were higher than the recommended dosage for children.

The ministry stated that it was discovered that the children had taken this syrup at home for two to seven days before they were admitted to the hospital, taking 2.5 to 5 ml three to four times per day, which was higher than the recommended dosage.

The syrup was used as a cold remedy by the parents.

The statement stated that Doc-1 Max tablets and syrups had been removed from all pharmacies in the nation following the deaths of 18 children. Seven employees had also been fired for failing to promptly analyze the situation and take appropriate action.

The Central Drugs Standard Control Organization (CDSCO - north zone) and Uttar Pradesh Drugs Controlling and Licensing Authority teams are working together on a joint investigation.

Uzbekistan has also been requested to provide a report on the casualty assessment.

Marion Biotech stated that it has received samples of the cough syrup from its manufacturing facility and is awaiting the test report.

The government is looking into the matter. The legal head of Marion Biotech Pharma Company, Hasan Raza, stated, "We will take action as per their report, for the time being, the manufacturing has stopped." This is the second time in a year that cough syrups manufactured in India have come under scrutiny.

Recently, passings of 70 kids in Gambia were connected to hack syrups made by Haryana-based Lady Drugs.

In October, the Central Drugs Standard Control Organization shut down its Sonepat unit for breaking manufacturing standards.

The World Health Organization (WHO) previously stated that a laboratory analysis of Maiden cough syrup revealed "unacceptable" levels of diethylene glycol and ethylene glycol, both of which have the potential to be toxic and cause acute kidney injury.

Drugs Controller General VG Somani told the WHO that government lab tests on samples of Maiden's products had "been found to be complying with specifications" and found no toxic substance.